Roche, Bristol-Myers Melanoma Therapies Boost Lives

REPLAY VIDEO
Your next video will start in
Pause

Recommended Videos

  • Info

  • Comments

June 6 (Bloomberg) -- An experimental drug from Roche Holding AG and Daiichi Sankyo Co. prolonged the lives of patients with melanoma in a study, a result that may lead to a second new treatment to fight deadly skin cancer. Shannon Pettypiece reports from the American Society of Clinical Oncology meeting in Chicago on Bloomberg Television's "In the Loop." (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change